CTO Lee Ann L. buys 100,000 shares of PRME at $1.13; cluster buy by 2+ insiders in 14 days as stock trades -84.7% from 52-week high.
Lee Ann L., Chief Technical Officer of Prime Medicine, purchased 100,000 shares at $1.13 on 2025-05-21, establishing a new position. This purchase is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The transaction occurs with PRME trading at $1.23, down -84.7% from its 52-week high of $8.03 and down -58.5% over the past 90 days. The company reported a latest quarterly revenue of $1.5M against a net loss of $-51.9M and remains unprofitable on a full-year basis, suggesting the company is in an early or challenging stage. The cluster buy activity at heavily depressed valuations—by multiple executives simultaneously—warrants investor attention to understand whether this reflects management's assessment of intrinsic value or other considerations.